Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. NVDA
4. MSTR
5. MU
6. DFTX
7. BAUFF
8. ICE
9. KR
10. RGA

Go back to Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
(NASDAQ: CMPX) Delayed: 2.06 +0.04 (1.98%)
Previous Close $2.02    52 Week High $ 
Open $2.05    52 Week Low $ 
Day High $2.08    P/E N/A 
Day Low $2.04    EPS $ 
Volume 144,811